Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Minerva Med ; 104(5): 497-504, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24101107

ABSTRACT

AIM: A lack of estrogen in postmenopausal women is an important factor causing the development of osteoporosis. Our purpose is to investigate the effects of Fibroblast Growth Factor 23 (FGF-23) on bone mineral metabolism and bone turnover. METHODS: Twenty-eight patients with postmenopausal osteoporosis (PMO), 32 patients with postmenopausal osteopenia and 30 healthy control subjects (postmenopausal non-osteoporosis) were included in this study. In order to assess the bone mineral metabolism; FGF 23, parathyroid hormone, vitamin D, calcium, phosphate, osteocalcin, alkaline phosphatase and hydroxyproline levels were measured. RESULTS: FGF 23 levels were found significantly higher in PMO group compared with postmenopausal osteopenia and control groups (P<0.01 and P<0.05 respectively). Urine hydroxyproline level was detected to be significantly lower in PMO patients compared with control group (P<0.01). Lomber and femur BMD levels were found to be significantly lower in PMO patients compared with postmenopausal osteopenia and control groups (P<0.001, P<0.001; P<0.001, P<0.001 respectively). On the other hand, when we categorized the PMO group subjects according to the age of menopause, the FGF 23 levels were found to be significantly higher in the group of menopausal age <5 years compared to the group of menopausal age >10 and to the group of menopausal age 5-10 years (P<0.05, P<0.05). CONCLUSION: We think our findings indicate that serum FGF 23 level is a significant determinant of increased bone turnover at early periods in PMO patients.


Subject(s)
Bone Density/physiology , Fibroblast Growth Factors/blood , Osteoporosis, Postmenopausal/blood , Alkaline Phosphatase/blood , Biomarkers/blood , Biomarkers/urine , Bone Diseases, Metabolic/blood , Bone Diseases, Metabolic/physiopathology , Bone Diseases, Metabolic/urine , Bone Remodeling/physiology , Calcium/blood , Calcium/urine , Case-Control Studies , Female , Fibroblast Growth Factor-23 , Humans , Hydroxyproline/blood , Hydroxyproline/urine , Middle Aged , Osteocalcin/blood , Osteoporosis, Postmenopausal/physiopathology , Osteoporosis, Postmenopausal/urine , Parathyroid Hormone/blood , Phosphorus/blood , Phosphorus/urine , Vitamin D/blood
2.
Eur J Anaesthesiol ; 25(9): 737-40, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18471340

ABSTRACT

BACKGROUND AND OBJECTIVE: Diphenhydramine has local anaesthetic and antimicrobial activity and may be used to prevent intravenous propofol injection pain. We studied the effect of adding diphenhydramine to propofol emulsions for preventing bacterial growth. METHODS: Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli and Candida albicans cultures were inoculated into the following solutions: 1% propofol, 0.05% diphenhydramine + 1% propofol, 0.1% diphenhydramine + 1% propofol, 0.2% diphenhydramine + 1% propofol, 0.3% diphenhydramine + 1% propofol, 1% diphenhydramine and 0.1% lidocaine + 1% propofol. A 100-microL of inoculum suspension adjusted for each of the micro-organisms was added separately to each tube and left at 20 degrees C. A 10-microL aliquot of each mixture was inoculated onto blood agar medium at 5 and 24 h. These plates were incubated at 35 degrees C for 24 h. Each plated medium was read, and the number of colony-forming units were counted and recorded (n = 2). Analysis of variance (ANOVA) with a post hoc Tukey HSD test and paired t-tests were used for data analysis. P < 0.05 was considered as significant. RESULTS: Diphenhydramine inhibited bacterial growth in propofol solutions in a dose-dependent manner. It was more effective than 0.1% lidocaine at similar concentrations in preventing bacterial growth for all organisms. CONCLUSION: Diphenhydramine had a significant inhibitory effect on bacterial growth in propofol.


Subject(s)
Anesthetics, Intravenous , Anesthetics, Local/pharmacology , Diphenhydramine/pharmacology , Drug Contamination/prevention & control , Propofol , Analysis of Variance , Candida albicans/drug effects , Candida albicans/growth & development , Dose-Response Relationship, Drug , Escherichia coli/drug effects , Escherichia coli/growth & development , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/growth & development , Staphylococcus aureus/drug effects , Staphylococcus aureus/growth & development
3.
Transplant Proc ; 38(5): 1530-4, 2006 06.
Article in English | MEDLINE | ID: mdl-16797351

ABSTRACT

BACKGROUND: Heart transplantation is an important therapeutic option for patients with end-stage disease, but is associated with major pulmonary complications. PATIENTS AND METHODS: We retrospectively reviewed the posttransplant follow-up of 34 orthotopic heart transplant recipients. RESULTS: Two of the 34 patients died of cardiac failure in the early postoperative period. Among the surviving patients, 10 (31.3%) developed pulmonary complications, all within the first 6 months: hospital-acquired bacterial pneumonia in five, fungal pneumonia in three, posttransplant lymphoproliferative disease in one, and community-acquired pneumonia in one patient. None of the patients developed transplantation-related malignancy. The overall mortality was 35.3%. Pneumonia-related mortality rate of 14.7% was due to early-onset nosocomial pneumonias, which were caused by bacterial and opportunistic microorganisms. Extrapulmonary causes of mortality were cardiac failure, meningitis, septicemia, and acute rejection. Cytomegalovirus antigenemia in the first month was associated with a poor prognosis. The frequency of pulmonary complications was higher among older patients and those who developed moderate rejection in the first month (P=.014 and P=.036, respectively). CONCLUSION: Pulmonary infections after heart transplantation occurred more frequently during the first 6 months posttransplantation, accounting for a significant portion of the posttransplantation mortality.


Subject(s)
Heart Transplantation/adverse effects , Lung Diseases/epidemiology , Adult , Anti-Bacterial Agents/therapeutic use , Female , Follow-Up Studies , Heart Diseases/classification , Heart Diseases/surgery , Humans , Immunosuppressive Agents/therapeutic use , Male , Middle Aged , Postoperative Complications/epidemiology , Retrospective Studies , Risk Factors , Smoking
4.
Eur J Cancer Care (Engl) ; 13(2): 135-44, 2004 May.
Article in English | MEDLINE | ID: mdl-15115469

ABSTRACT

The Turkish version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire version 2.0 (EORTC QLQ-C30 v.2.0) has started to be used in clinical trials recently. The objective of the study was to evaluate the validity and reliability of the Turkish version of the EORTC QLQ-C30 v.2.0 and the correlation between the Karnofsky Performance Scale (KPS) and the EORTC QLQ-C30. Two hundred and two lung cancer patients were included in the study between January and March 2000. All the subscales met the minimal standards of reliability (Cronbach's alpha > or = 0.70). Only the role functioning scale differed among the three disease stages of patients (local, locoregional and metastatic). There was no statistically significant difference among therapy types. All interscale correlations were statistically significant (P < 0.01). The strongest correlations were found among the physical functioning, role functioning and fatigue scales. Social functioning was closely related with physical, role, emotional and cognitive functioning. The weakest correlations were between nausea/vomiting and the other scales. Global quality of life (QOL) was substantially correlated with most of the scales except cognitive functioning. The coefficients for the correlation between the items differed between 0.12 and 0.97 and all the subscales were strongly correlated with the scales which they formed. The highest correlation between the EORTC QLQ-C30 and KPS was for physical functioning (r = 0.62, P < 0.05). The Turkish version of the EORTC QLQ-C30 is a valid (by means of interscales validity) and reliable instrument for Turkish lung cancer patients and can be used in clinical studies but needs supporting by the reference data on the QOL of the Turkish population.


Subject(s)
Lung Neoplasms/psychology , Quality of Life , Activities of Daily Living , Adult , Aged , Aged, 80 and over , Female , Health Status Indicators , Humans , Karnofsky Performance Status , Lung Neoplasms/diagnosis , Lung Neoplasms/therapy , Male , Middle Aged , Sensitivity and Specificity , Sickness Impact Profile , Surveys and Questionnaires , Turkey
5.
Tex Heart Inst J ; 28(2): 83-8, 2001.
Article in English | MEDLINE | ID: mdl-11453137

ABSTRACT

To determine the nature of neurologic dysfunction after deep hypothermic circulatory arrest during aortic arch surgery, we reconsidered the cases of 154 patients who had undergone aortic arch surgery (either of the ascending or transverse aorta, or both) between November 1993 and July 1999. Temporary postoperative neurologic dysfunction was seen in 9 patients (5.8%), and another 3 patients (1.9%) experienced stroke. Patients with temporary neurologic dysfunction had no new infarct and were discharged home with no residual symptoms. Computed tomographic scans revealed that 2 patients with stroke had multiple infarcts in the brainstem, and the 3rd had bilateral border-zone infarcts. The patients with brainstem infarcts died on postoperative days 7 and 15, and the patient with border-zone infarct was discharged home with no symptoms 3 months after surgery. Univariate analysis revealed that patients with neurologic deficits had significantly higher rates of history of hypertension, concomitant coronary artery bypass grafting, cardiac ischemia times longer than 90 minutes, and chronic renal failure. A multivariate logistic regression analysis revealed that the significant preoperative variables associated with neurologic deficits were a history of hypertension and a cardiac ischemia time longer than 90 minutes. Deep hypothermic circulatory arrest is a safe and useful technique for protection of the brain during surgery for complex aortic problems. In future, some patients at extreme risk for perioperative neurologic complications might be offered novel neuroprotective agents, in combination with deep hypothermia.


Subject(s)
Brain Diseases/etiology , Heart Arrest, Induced/adverse effects , Adult , Aged , Aortic Aneurysm, Thoracic/surgery , Female , Humans , Male , Middle Aged , Retrospective Studies , Time Factors
6.
J Clin Microbiol ; 37(12): 4189-91, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10565962

ABSTRACT

We evaluated cord formation in MB/BacT broth as a rapid method for presumptive identification of the Mycobacterium tuberculosis complex. Kinyoun acid-fast-stained smears from 370 positive MB/BacT bottles were examined for the presence of serpentine cording. The smears were examined independently by two observers. Observer 1 (the supervisor of the mycobacteriology laboratory) examined all of the smears while observer 2 (a clinical microbiologist not familiar with acid-fast bacillus [AFB] microscopy) examined 148 randomly chosen smears that were read by observer 1 without knowledge of which smear was which. The sensitivity, specificity, and positive and negative predictive values of cording for the presumptive identification of M. tuberculosis read by observer 1 were 88.2, 97.4, 99.2, and 69.7%, respectively. These values were reported at 90.6, 52.3, 82.8, and 69. 7%, respectively, by observer 2. Our laboratory prevalence of M. tuberculosis among positive cultures was 78% during the time this study was conducted. At the time of positive signal of the MB/BacT bottles, the broth of the bottles had sufficient cell mass to allow for observation of the presence or absence of serpentine cording. The presence of cords in MB/BacT broth is a reliable criterion for rapid, predictive identification of the M. tuberculosis complex for laboratories with a high proportion of the M. tuberculosis complex when the smears are examined by a microbiologist who has experience with AFB staining.


Subject(s)
Cord Factors/metabolism , Mycobacterium tuberculosis/classification , Mycobacterium tuberculosis/growth & development , Tuberculosis/microbiology , Bacterial Typing Techniques , Culture Media , Humans , Laboratories , Mycobacterium tuberculosis/metabolism , Predictive Value of Tests , Respiratory System/microbiology , Sensitivity and Specificity
7.
J Thorac Cardiovasc Surg ; 118(2): 306-15, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10425004

ABSTRACT

OBJECTIVE: Renal failure is known to increase the morbidity and mortality in patients undergoing cardiac surgery. The results of heart surgery in patients with non-dialysis-dependent, mild renal insufficiency are not clear. METHODS: One hundred nineteen adult patients with chronic renal failure underwent cardiac surgery. Group I consisted of 93 patients who had creatinine levels between 1.6 and 2.5 mg/dL but who were not supported by dialysis. Group II consisted of 18 patients with creatinine levels higher than 2.5 mg/dL who were not supported by dialysis. Group III consisted of 8 patients with end-stage renal disease who were receiving hemodialysis. RESULTS: The hospital mortality rates were 11.8%, 33.0%, and 12.5%, respectively. Morbidity was 21.5%, 44.4%, and 75.0%, respectively, in groups I, II, and III. Postoperative hemodialysis was needed in 2 (2.15%) patients from group I and 6 (33%) patients from group II. On multivariable logistic regression analysis, risk factors for mortality were preoperative creatinine level more than 2.5 mg/dL, angina class III-IV, emergency operation, excessive mediastinal hemorrhage, postoperative pulmonary insufficiency, low cardiac output, and rhythm disturbances. Risk factors for morbidity were preoperative creatinine level more than 2.5 mg/dL and postoperative dialysis. CONCLUSIONS: Chronic renal failure increases the mortality and morbidity in patients undergoing cardiac surgery. Renal insufficiency with creatinine levels higher than 2.5 mg/dL increases the risk of postoperative dialysis and prolongs the length of hospital stay. Careful preoperative management and intraoperative techniques, such as avoiding low perfusion pressure and using low-dose dopamine, may be useful for a good operative outcome.


Subject(s)
Cardiac Surgical Procedures/methods , Cardiopulmonary Bypass , Heart Diseases/surgery , Kidney Failure, Chronic/complications , Adult , Aged , Aged, 80 and over , Cardiac Surgical Procedures/mortality , Cardiopulmonary Bypass/mortality , Creatinine/blood , Female , Follow-Up Studies , Heart Diseases/complications , Heart Diseases/mortality , Hospital Mortality , Humans , Kidney Failure, Chronic/blood , Kidney Failure, Chronic/mortality , Length of Stay , Male , Middle Aged , Postoperative Complications/mortality , Retrospective Studies , Risk Factors , Survival Rate , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...